Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PALIVIZUMAB vs PAMIDRONATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PALIVIZUMAB vs PAMIDRONATE: Safety Overview

Metric PALIVIZUMAB PAMIDRONATE
Total FAERS Reports 11,419 1,639
Deaths Reported 1,248 184
Death Rate 10.9% 11.2%
Hospitalizations 6,461 484
Average Patient Age 0.8 yrs 55.1 yrs
% Female Patients 42.2% 61.6%
FDA Approval Date N/A Apr 30, 2001
Manufacturer Swedish Orphan Biovitrum AB (publ) Hospira, Inc.
Route INTRAMUSCULAR INTRAVENOUS
Marketing Status Prescription Discontinued